About Cookies on This Site

This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.

Connect with us: 1-844-737-2223

Monday through Friday, 8:30 am to 8:30 pm ET

 
 
WELCOME, HEALTHCARE PROVIDERS
 

an essential
connection.Yellow heart for 'support with heart' reflects Acadia Connect support program for patients, caregivers & healthcare providers

 

Acadia Connect™ helps ensure that it's easy for your patients to get the support they need to start and continue their treatment.

 
 
 
 
 

Acadia Connect is a comprehensive support program for patients prescribed treatments from Acadia Pharmaceuticals that offers guidance on enrollment, patient access, insurance coverage, financial assistance, and prescription support.

 
 
 

ACADIA CONNECT
CAN HELP WITH:

 
 
 
Illustration of white umbrella above a dark blue heart inside a crest icon represents Acadia Connect cost & insurance support
 
 

COST & INSURANCE

Providing benefits verification, prior authorization assistance, financial support resources, and a free 14-day supply to help patients access their medication*

 
 
 
 
Yellow icon with white 'Rx' text & lines reflect Acadia Connect prescription filling & delivery coordination with pharmacies
 
 

FILLING PRESCRIPTIONS

Coordinating with your patient and the pharmacy to help get prescriptions filled and delivered to their preferred location

 
 
 
 
Dark blue heart within lighter blue callout square over another square callout reflects Acadia Connect answering questions about support program & services for patients & caregivers
 
 

SUPPORT & EDUCATION

Sharing guidance to help your patients understand the services Acadia Connect offers and access to the medicine you prescribed

 
 
 
 

GET TO KNOW YOUR TEAM

 
Holding hands to provide comfort reflects Acadia Connect local Patient Access Managers supporting HCPs & their patients
Holding hands to provide comfort reflects Acadia Connect local Patient Access Managers supporting HCPs & their patients
 
 
 

GET TO KNOW YOUR TEAM

 

we’re here to connect you and your patients to the right support every day.

 

YOUR PATIENT ACCESS MANAGER

Your office will be paired with a local Patient Access Manager who offers in-office education and resources to help facilitate access to the medication you prescribe.*

 

They help with:

  • Sharing expertise on payer coverage and criteria
  • Facilitating and supporting Acadia Connect cases
  • Navigating and resolving patient access issues
  • Providing an overview of access services and offerings
  • Educating patients about available financial assistance options
  • Keeping you informed if there is an interruption in the treatment regimen you prescribed
 

 
 

YOUR CARE COORDINATOR

Your enrolled patients will be assigned a dedicated Care Coordinator they can turn to for insurance questions and financial resources.

 

They help with:

  • Managing treatment forms submitted to Acadia Connect
  • Navigating insurance and managing costs
  • Confirming insurance coverage and expectations about the process
  • Working with the pharmacies to fill patients’ prescriptions
  • Ensuring patients are connected with available financial assistance options (if eligible)
  • Answering questions about Acadia Connect
 
 
 
ENROLL YOUR PATIENTS HERE
 
Yellow Red Cross emblem inside teal bubble icon reflects healthcare provider in-office care & prescription enrollment for patients
 

for in-office care.

 

If you need to get a prescription for your patient, fill out the treatment form, including the section for the free 14-day supply.*

 
START TREATMENT FORM
 
Yellow Red Cross symbol on teal house icon reflects healthcare provider long-term care prescription enrollment for patients
 
 

for long-term care.

 

If you need long-term care access services, fill out the long-term care service request form.

START SERVICE REQUEST FORM
 

*Appropriate patients must be enrolled in Acadia Connect to be eligible for the free 14-day supply. Acadia Connect patient eligibility and terms and conditions apply.

 
 
Important Safety Information and Indication for NUPLAZID® (pimavanserin)


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS

  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
  • NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.
  • Contraindication: NUPLAZID is contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components. Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported.
  • Warnings and Precautions: QT Interval Prolongation
    • NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics or Class 3 antiarrhythmics, certain antipsychotic medications, and certain antibiotics.
    • NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and presence of congenital prolongation of the QT interval.
  • Adverse Reactions: The common adverse reactions (≥2% for NUPLAZID and greater than placebo) were peripheral edema (7% vs 2%), nausea (7% vs 4%), confusional state (6% vs 3%), hallucination (5% vs 3%), constipation (4% vs 3%), and gait disturbance (2% vs <1%).
  • Drug Interactions:
    • Coadministration with strong CYP3A4 inhibitors (e.g., ketoconazole) increases NUPLAZID exposure. Reduce NUPLAZID dose to 10 mg taken orally as one tablet once daily.
    • Coadministration with strong or moderate CYP3A4 inducers reduces NUPLAZID exposure. Avoid concomitant use of strong or moderate CYP3A4 inducers with NUPLAZID.
 

Indication

NUPLAZID is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

Dosage and Administration

Recommended dose: 34 mg capsule taken orally once daily, without titration.

NUPLAZID is available as 34 mg capsules and 10 mg tablets.

Please read the full Prescribing Information, including Boxed WARNING.

NUPLAZID is a registered trademark of Acadia Pharmaceuticals Inc.

 
 
Enrollment >